R1 RCM Inc (RCM):企業の財務・戦略的SWOT分析

◆英語タイトル:R1 RCM Inc (RCM) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDTC193802FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Technology and Communications
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

R1 RCM Inc (RCM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

R1 RCM Inc (R1), offers hospital and health systems solutions. The company’s RCM services helps to solve and transform revenue cycle performance challenges across health physician groups. Its services comprise, bill preparation and collections, patient registration, medical treatment documentation and coding, insurance and benefit verification. R1 also offers practice management, revenue integrity services, patient experience, and physician advisory services. These offerings helps hospitals and medical facilities in complying with payer requirements for billing purposes. The company serves healthcare systems, physician practice groups and other healthcare organizations. R1 is headquartered in Chicago, Illinois, the US.

R1 RCM Inc Key Recent Developments

Feb 18,2021: R1 RCM Reports Fourth Quarter and Full Year 2020 Results
Nov 03,2020: R1 RCM reports third quarter 2020 results
Oct 28,2020: LifePoint Health and R1 RCM announce partnership to deliver revenue cycle excellence and enhance patient experience
Oct 20,2020: R1 RCM to Release Third Quarter 2020 Results on November 3
Sep 29,2020: R1 increases footprint in hospital-based physician market with addition of prominent emergency physician groups

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
R1 RCM Inc – Key Facts
R1 RCM Inc – Key Employees
R1 RCM Inc – Key Employee Biographies
R1 RCM Inc – Major Products and Services
R1 RCM Inc – History
R1 RCM Inc – Company Statement
R1 RCM Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
R1 RCM Inc – Business Description
Product Category: Incentive Fees
Performance
Product Category: Net Operating Fees
Performance
Product Category: Other
Performance
R1 RCM Inc – Corporate Strategy
R1 RCM Inc – SWOT Analysis
SWOT Analysis – Overview
R1 RCM Inc – Strengths
R1 RCM Inc – Weaknesses
R1 RCM Inc – Opportunities
R1 RCM Inc – Threats
R1 RCM Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
R1 RCM Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Feb 18, 2021: R1 RCM Reports Fourth Quarter and Full Year 2020 Results
Nov 03, 2020: R1 RCM reports third quarter 2020 results
Oct 28, 2020: LifePoint Health and R1 RCM announce partnership to deliver revenue cycle excellence and enhance patient experience
Oct 20, 2020: R1 RCM to Release Third Quarter 2020 Results on November 3
Sep 29, 2020: R1 increases footprint in hospital-based physician market with addition of prominent emergency physician groups
Aug 04, 2020: R1 RCM reports second quarter 2020 results
Aug 03, 2020: RUSH and R1 launch Innovation Lab to drive Industry-Leading quality and patient experience
Jun 01, 2020: R1 Drivescontinued growth in physician revenue cycle management market with addition of Pinnacle Dermatology
May 05, 2020: R1 RCM reports first quarter 2020 results
May 04, 2020: R1 RCM appoints Rachel Wilson as executive vice president and chief financial officer
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
R1 RCM Inc, Key Facts
R1 RCM Inc, Key Employees
R1 RCM Inc, Key Employee Biographies
R1 RCM Inc, Major Products and Services
R1 RCM Inc, History
R1 RCM Inc, Subsidiaries
R1 RCM Inc, Key Competitors
R1 RCM Inc, Ratios based on current share price
R1 RCM Inc, Annual Ratios
R1 RCM Inc, Annual Ratios (Cont...1)
R1 RCM Inc, Annual Ratios (Cont...2)
R1 RCM Inc, Interim Ratios
R1 RCM Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[R1 RCM Inc (RCM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tikcro Technologies Ltd (TIKRF):企業の財務・戦略的SWOT分析
    Summary Tikcro Technologies Ltd (Tikcro) is a biotechnology company that discovers, develops, manufactures and markets antibodies. The company undertakes clinical trials for its pipeline products PD1, PDL1, PDL2, TIGIT and CTLA-4 products, among others. Its products are based on 3D antigens designed …
  • Hutchison 3G UK Limited:戦略・SWOT・企業財務分析
    Hutchison 3G UK Limited - Strategy, SWOT and Corporate Finance Report Summary Hutchison 3G UK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sasol Ltd (SOL)-石油・ガス分野:企業M&A・提携分析
    Summary Sasol Ltd (Sasol) is an integrated energy and chemical company. It develops and commercializes technologies; and builds and operates facilities to produce a range of products, including liquid fuels, chemicals, and low-carbon electricity. The company’s product offerings include olefins and s …
  • Network Rail Limited:企業の戦略・SWOT・財務情報
    Network Rail Limited - Strategy, SWOT and Corporate Finance Report Summary Network Rail Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Cortec GmbH:製品パイプライン分析
    Summary Cortec GmbH (Cortec), a subsidiary of Iron Force Industrial Co Ltd is a medical device company that develops neurons technology platform for the measurement and stimulation of brain activity. The company provides products for clinical use and scientific research. It is developing implants th …
  • Wabash Valley Power Association, Inc.:企業の戦略的SWOT分析
    Wabash Valley Power Association, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Autoliv Inc (ALV):企業の財務・戦略的SWOT分析
    Autoliv Inc (ALV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Koppers Holdings Inc (KOP):企業の財務・戦略的SWOT分析
    Koppers Holdings Inc (KOP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Fufeng Group Limited:企業の戦略・SWOT・財務情報
    Fufeng Group Limited - Strategy, SWOT and Corporate Finance Report Summary Fufeng Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • OGE Energy Corp (OGE):企業の財務・戦略的SWOT分析
    OGE Energy Corp (OGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Oasmia Pharmaceutical AB (OASM):企業の財務・戦略的SWOT分析
    Summary Oasmia Pharmaceutical AB (Oasmia Pharmaceutical) is a pharmaceutical company that develops, manufactures, markets and sells drugs for human and veterinary oncology. The company’s pipeline for human health includes apealea (paclical), currently at registration and approval stage, for treating …
  • Nestle Australia Ltd:企業の戦略・SWOT・財務情報
    Nestle Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Nestle Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Patheon NV:戦略・SWOT・企業財務分析
    Patheon NV - Strategy, SWOT and Corporate Finance Report Summary Patheon NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Lynntech Inc:企業の製品パイプライン分析
    Summary Lynntech Inc (Lynntech) is a diversified company. The company designs, fabricates and refines fuel cell test stations for research. It conducts research and development in the areas of energy, power, life sciences, materials science, therapeutics and diagnostics, chemical and environmental s …
  • Eli Lilly and Company:企業のM&A・事業提携・投資動向
    Eli Lilly and Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eli Lilly and Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • The Lubrizol Corporation:企業の戦略・SWOT・財務分析
    The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report Summary The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Lay Hong Berhad (LAYHONG):企業の財務・戦略的SWOT分析
    Lay Hong Berhad (LAYHONG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • FibroGen Inc (FGEN)-製薬・医療分野:企業M&A・提携分析
    Summary FibroGen Inc (FibroGen) is a biotechnology company that discovers, develops and commercializes new therapeutics. The company’s pipeline product portfolio includes FG-4592, an oral small molecule inhibitor of HIF prolyl hydroxylases that is used for the treatment of anemia in chronic kidney d …
  • Deutsche Bank AG:企業のM&A・事業提携・投資動向
    Deutsche Bank AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Deutsche Bank AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Dataprep Holdings Bhd (DATAPRP):企業の財務・戦略的SWOT分析
    Dataprep Holdings Bhd (DATAPRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆